Skip to main content
Clinical Trials/ISRCTN16818128
ISRCTN16818128
Active, not recruiting
Phase 4

Cerebrolysin as add-on therapy in patients with high Hunt-Hess grade subarachnoidal hemorrhage

niversity Hospital Centre Zagreb0 sites50 target enrollmentJuly 10, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospital Centre Zagreb
Enrollment
50
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2023
End Date
January 1, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity Hospital Centre Zagreb

Eligibility Criteria

Inclusion Criteria

  • 1\. Aneurysmal subarachnoidal haemorrhage
  • 2\. Inital Hunt\-Hess grade 3 or higher
  • 3\. Endovasculary secured aneurysm
  • 4\. Availability to add\-on treatment not more than 24 hours after embolisation

Exclusion Criteria

  • 1\. Known allergy to Cerebrolysine
  • 2\. Refusal of participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
The efficacy of Cerebrolysin in the treatment of acute ischemic strokeCerebral infarction.Cerebral infarction
IRCT138803272042N1Research Deputy, Shahid Beheshti University of Medical Sciences100
Completed
Phase 2
Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosis
ISRCTN38393880Instituto Cardiológico Banfield20
Completed
Not Applicable
Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapyAcute ischemic strokeCirculatory SystemStroke, not specified as haemorrhage or infarction
ISRCTN15233803niversity Hospital Centre Zagreb46
Unknown
Phase 2
Feasibility study of Cerebrolysin therapy in pre-hospital treatment of patients with acute strokeEarlier treatment after stroke onset improves long-term outcome. Pre-hospital treatment for stroke will be an important part of future stroke treatment. Early administration of neuroprotective agents could be beneficial for stroke patientscerebrolysin, ambulance, mobile stroke unit, stroke
TCTR20220310004Chulalongkorn Stroke Center20
Active, not recruiting
Phase 1
Is Cerebrolysin efficient in neurorecovery after moderate-severe traumatic brain injury?Moderate-severe traumatic brain injuryMedDRA version: 26.1Level: LLTClassification code 10060690Term: Traumatic brain injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2022-003382-38-ROFSNANO05012022440